| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/01/2005 | CN1621035A Injection of flurbiprofen and its preparing method |
| 06/01/2005 | CN1621034A Freeze dry powder injection of ketoprofen |
| 06/01/2005 | CN1621033A Method for producing multiple in-phase mature ovum by diethyl stilbestrol |
| 06/01/2005 | CN1621030A Oral solid preparation of water indissoluble medicine and/or acid sensitive medicinal composition |
| 06/01/2005 | CN1620935A Amylose, polypeptide functional blueberry drink and production process |
| 06/01/2005 | CN1620920A Composite fungi amylose nutrient |
| 06/01/2005 | CN1620893A Compound immunopotentiator for prawn breeding |
| 06/01/2005 | CN1204249C Kelp sugar-releasing enzyme, preparation and application of the same |
| 06/01/2005 | CN1204144C Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 06/01/2005 | CN1204141C Salts of D-fructose-1, 6-bis(dihydrogen phosphate) with organic amine and pharmaceutical compositions containing them |
| 06/01/2005 | CN1204139C Remedies for neuropathic pain and model animals of neuropathic pain |
| 06/01/2005 | CN1204138C Pyrazolo [4, 3-d] pyrimidine derivs. |
| 06/01/2005 | CN1204135C 1, 3-dioxolanes with antitussive activity |
| 06/01/2005 | CN1204134C Sulfamine-substituted benzodihydopyran, preparation method, use as medicine or diagnostic reagent and medicine containing same |
| 06/01/2005 | CN1204122C Process for separating optically active ethyl (3R, 5S, 6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3, 5-dihydroxy-6-heptenoate |
| 06/01/2005 | CN1204121C 1, 4-substituted cyclic amine derivatives or dihydro indole derivatives and medicines containing same |
| 06/01/2005 | CN1204020C Terminally sterilized topical patch preparation and production methods thereof |
| 06/01/2005 | CN1203899C Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy |
| 06/01/2005 | CN1203896C Low substituted ethylene-lactic cellulose and solid preparation |
| 06/01/2005 | CN1203895C Topical compositions containing prostaglandin E1 |
| 06/01/2005 | CN1203894C Anti-cancer medicine composition |
| 06/01/2005 | CN1203891C Medicine for treating coronary heart disease and its preparation method |
| 06/01/2005 | CN1203886C Medicine for treating cardiovascular diseases and its preparing method |
| 06/01/2005 | CN1203874C External-used burn and scald treating medicine and its prepn. process |
| 06/01/2005 | CN1203873C Medicine for treating epistaxis |
| 06/01/2005 | CN1203867C Use of refined fur seal oil for preparing medicine for preventing and treating senile dementia |
| 06/01/2005 | CN1203866C Soluble nutritious powder with multiple elements, vitamins and amino acids and its preparation method |
| 06/01/2005 | CN1203864C Spray formulation of providone iodine |
| 06/01/2005 | CN1203863C Use of pet food compositions containing fermentable fiber |
| 06/01/2005 | CN1203862C Compound glucose injection with clindamycin and metronidazole |
| 06/01/2005 | CN1203861C Cerebrovascular regeneration/reconstruction promoters and nerve tissue secondary degeneration inhibitors comprising ginsenoside Rb1 |
| 06/01/2005 | CN1203860C Application of Na-ion channel blocker and aspirin in preparing antalgic medicine for mammal |
| 06/01/2005 | CN1203859C Medicine for curing toothache |
| 06/01/2005 | CN1203858C Pharmaceutically active morpholinol |
| 06/01/2005 | CN1203857C Method for localized anesthesia and analgesia |
| 06/01/2005 | CN1203856C Dispersion tablet of vasilowy hydrochlaride and its preparation method |
| 06/01/2005 | CN1203855C Pharmaceutical solutions for levosimendan |
| 06/01/2005 | CN1203854C Compositions having improved delivery of actives |
| 06/01/2005 | CN1203853C Special ingredient extract of tetrandra root and its use |
| 06/01/2005 | CN1203852C Valdecoxib compositions |
| 06/01/2005 | CN1203851C Use of inhibitor produced or released by reactive oxygen metablite in producing pharmaceutical |
| 06/01/2005 | CN1203850C Effervescent vitamin C granule and its preparation method |
| 06/01/2005 | CN1203849C Remedy for keratoconjunctival diseases |
| 06/01/2005 | CN1203848C P-ethyl phenol aminophenol anal injection for children and its preparationn method |
| 06/01/2005 | CN1203847C Chemically-defined non-polymeric valency plateform molecules and conjugates thereof |
| 06/01/2005 | CN1203846C Biphasic controlled release delivery system for high solubility pharmaceuticals and method |
| 06/01/2005 | CN1203845C Pharmaceutical composition comprising profen |
| 06/01/2005 | CN1203844C Solid themoformable pharmaceutical composition for the controlled release of ivabradine |
| 06/01/2005 | CN1203843C Preparation method of high-content oil-soluble vitamin slow-releasing microcapsule powder |
| 06/01/2005 | CN1203842C Arificial tear solution |
| 06/01/2005 | CN1203775C Feed coposition for broilers and method for breeding broilers |
| 05/31/2005 | US6900354 3-phenyl-propionamido, 3-phenyl-acrylamido and 3-phenyl-propynamido derivatives |
| 05/31/2005 | US6900353 Cyclopentyl sulfonamide derivatives |
| 05/31/2005 | US6900345 Antibiotics; mutilin 14-[N-(2-carbamoyloxyethoxycarbonyl)]carbamate; therapy for bacteria infections; chemical synthesis |
| 05/31/2005 | US6900338 Scavenger compounds |
| 05/31/2005 | US6900336 8-aza-11-deoxy prostaglandin analogues |
| 05/31/2005 | US6900334 Antiallergens; autoimmune diseases |
| 05/31/2005 | US6900331 Derivatives of epothilone B and D and synthesis thereof |
| 05/31/2005 | US6900329 MCH antagonists and their use in the treatment of obesity |
| 05/31/2005 | US6900327 Used as antidepressants, to treat obsessive compulsive disorder, panic disorders, bulimia, anorexia, pain, obesity, senile demential, migraines, and social phobias |
| 05/31/2005 | US6900323 The present invention is directed to a series of chemical entitites that express HIV-1 inhibitory activities. |
| 05/31/2005 | US6900319 Carbo- and heterocyclic amidines |
| 05/31/2005 | US6900318 1,4,5,6-tetrahydropyrimidine derivative as a vitronectin inhibitor |
| 05/31/2005 | US6900311 O-sulphated bacterial polysaccharides and their use |
| 05/31/2005 | US6900309 Aminocarbonylation reaction of a adenosine compound containing purine base and pentofuranosyl sugar and a leaving group at 2 position of purine ring, with an amine compound in presence of carbon monoxide and suitable coupling catalyst |
| 05/31/2005 | US6900245 Pharmaceutical composition comprising crystalline sibutramine methanesulfonate hemihydrate |
| 05/31/2005 | US6900244 Controlling lipid, cholesterol metabolism; anticholesterol agents |
| 05/31/2005 | US6900243 Phenylheteroalkylamine derivatives |
| 05/31/2005 | US6900242 Compound for use in the treatment of cancer and prevention of infections |
| 05/31/2005 | US6900241 Compositions for, and methods of, treating atherosclerosis |
| 05/31/2005 | US6900240 Enriched in at least two of the phytochemicals selected from the group consisting of isoflavones, lignans, saponins, catechins and phenolic acids. |
| 05/31/2005 | US6900238 HIV protease inhibitors |
| 05/31/2005 | US6900236 Cannabimimetic indole derivatives |
| 05/31/2005 | US6900235 Anticancer agents; viricides |
| 05/31/2005 | US6900234 Hypotensive agents; congestive heart failure; using mixture of enzyme inhibitors of renin, angiotensin converting enzyme and angiotensin antagonist |
| 05/31/2005 | US6900232 For therapy of tumor metastasis, solid tumor growth (neoplasia), osteoporosis, Paget's disease, humoral hypercalcemia of malignancy, osteopenia, angiogenesis, including tumor angiogenesis and lymphangiogenesis |
| 05/31/2005 | US6900231 Aminopyridyl-substituted phenyl acetamides as protease inhibitors |
| 05/31/2005 | US6900230 Heterocyclo-alkylsulfonyl pyrazoles as anti-inflammatory/analgesic agents |
| 05/31/2005 | US6900229 Prodrugs of 1-methyl-2-(4-amidinophenylaminomethyl)-benzimidazol-5-yl-carboxylic acid-(N-2-pyridyl-N-2-hydroxycarbonylethyl)-amide |
| 05/31/2005 | US6900227 Benzodioxole derivatives |
| 05/31/2005 | US6900226 Quinoline and quinazoline derivatives; prophylaxis or treatment of arthritis, cardiovascular diseases, diabetes, renal failure and particularly eating disorders and obesity. |
| 05/31/2005 | US6900225 Quinolonecarboxylic acid derivative |
| 05/31/2005 | US6900224 Effective against a broad range of pathogenic microorganisms with advantages in low susceptibility to microbial resistance, reduced toxicity, and improved pharmacology. |
| 05/31/2005 | US6900222 Relaxant drugs; antiulcer agents |
| 05/31/2005 | US6900221 Crystalline polymorph of erlotinib hydrochloride; synthesis; treating cancer |
| 05/31/2005 | US6900220 Quinazolone derivatives as alpha 1A/B adrenergic receptor antagonists |
| 05/31/2005 | US6900219 ABCA-1 elevating compounds |
| 05/31/2005 | US6900218 Reducing oxidation stresses; central nervous system disorders; antiinflammatory agents |
| 05/31/2005 | US6900216 Psychological disorders; antidepressants; brain diosrders; anticonvulsants |
| 05/31/2005 | US6900214 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases |
| 05/31/2005 | US6900212 Anxiolytic agents; psychological disorders; sexual disorders; eating disorders |
| 05/31/2005 | US6900211 CCR5 antagonists useful for treating aids |
| 05/31/2005 | US6900208 Antiinflammatory agents; osteoporosis; anticancer agents |
| 05/31/2005 | US6900207 N-containing five-membered ring compounds and pharmaceutical agents comprising the same as active ingredient |
| 05/31/2005 | US6900205 Antidiabetic agents |
| 05/31/2005 | US6900203 Optically active fluorinated vasoconstrictors, methods for making them, and anesthetic formulations comprising them |
| 05/31/2005 | US6900202 Nicotinic acetylcholine receptor activators; treating neurodegenerative disorders |
| 05/31/2005 | US6900201 N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 05/31/2005 | US6900200 Tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists |
| 05/31/2005 | US6900199 Central nervous system disorders; prevention amyloid deposits; Alzheimer's disease; Down sydrome |